# GeoVax Labs, Inc.: filings

GOVX · Nasdaq · CIK 832489 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/govx.md) · [Financials](/companies/govx/financials.md) · [Filings](/companies/govx/filings.md) · [Insiders](/companies/govx/insiders.md)

## Reports and events: 353 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 223, 8-K 207, 424B3 100, 10-Q 53, EFFECT 53, POS AM 38, CORRESP 30, DEF 14A 25, SC 13G/A 22, S-1 21, UPLOAD 20, 10-K 18, PRE 14A 17, 424B1 16, S-1/A 15, 424B5 14, SCHEDULE 13G/A 12, D 11, 3 10, DEFA14A 10, SC 13G 9, 10-K/A 7, SC 13D/A 7, POS EX 6, SCHEDULE 13G 5, 424B4 3, AW 3, PRER14A 3, D/A 2, DRS 2, RW 2, S-3 2, S-8 2, 25-NSE 1, 4/A 1, 8-A12B 1, CERT 1, DEFR14A 1, DRSLTR 1, NT 10-K 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 13:00 ET | [8-K](/filings/0001437749-26-033610.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-033610 |
| 2026-10-27 | 09:00 ET | [8-K](/filings/0001437749-26-033566.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-033566 |
| 2026-09-17 | 16:06 ET | [S-1](/filings/0001437749-26-030676.md) | Registration statement | 0001437749-26-030676 |
| 2026-09-10 | 16:41 ET | [DEF 14A](/filings/0001437749-26-030089.md) | Proxy statement, period 2026-10-27 | 0001437749-26-030089 |
| 2026-09-10 | 16:35 ET | [8-K](/filings/0001437749-26-030085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030085 |
| 2026-08-28 | 16:16 ET | [8-K](/filings/0001437749-26-029184.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-26-029184 |
| 2026-08-28 | 16:09 ET | [8-K](/filings/0001437749-26-029181.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-029181 |
| 2026-07-27 | 16:34 ET | [10-Q](/filings/0001437749-26-024523.md) | Quarterly report, period 2026-06-30 | 0001437749-26-024523 |
| 2026-07-27 | 16:33 ET | [8-K](/filings/0001437749-26-024522.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024522 |
| 2026-07-10 | 16:04 ET | [8-K](/filings/0001437749-26-023320.md) | 3.01 Delisting notice | 0001437749-26-023320 |
| 2026-06-17 | 16:32 ET | [8-K](/filings/0001437749-26-020984.md) | 5.07 Shareholder vote results | 0001437749-26-020984 |
| 2026-05-26 | 09:00 ET | [S-1](/filings/0001437749-26-018320.md) | Registration statement | 0001437749-26-018320 |
| 2026-05-19 | 17:04 ET | [8-K](/filings/0001437749-26-017809.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017809 |
| 2026-05-14 | 16:23 ET | [8-K](/filings/0001437749-26-017070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017070 |
| 2026-05-14 | 16:07 ET | [10-Q](/filings/0001437749-26-017048.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017048 |
| 2026-05-07 | 16:27 ET | [8-K](/filings/0001437749-26-015613.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-015613 |
| 2026-04-27 | 16:10 ET | [DEF 14A](/filings/0001437749-26-013468.md) | Proxy statement, period 2026-06-17 | 0001437749-26-013468 |
| 2026-04-16 | 17:41 ET | [S-1](/filings/0001437749-26-012440.md) | Registration statement | 0001437749-26-012440 |
| 2026-04-16 | 17:40 ET | [S-1](/filings/0001437749-26-012439.md) | Registration statement | 0001437749-26-012439 |
| 2026-04-15 | 17:20 ET | [8-K](/filings/0001437749-26-012435.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-012435 |
| 2026-04-15 | 15:57 ET | [10-K](/filings/0001437749-26-012377.md) | Annual report, period 2025-12-31 | 0001437749-26-012377 |
| 2026-03-31 | 17:15 ET | [8-K](/filings/0001437749-26-010733.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-010733 |
| 2026-02-17 | 17:21 ET | [8-K](/filings/0001437749-26-004392.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004392 |
| 2026-01-12 | 16:31 ET | [8-K](/filings/0001437749-26-001113.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-001113 |
| 2025-12-22 | 16:35 ET | [8-K](/filings/0001437749-25-038547.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-038547 |
| 2025-12-12 | 17:26 ET | [S-1](/filings/0001437749-25-037757.md) | Registration statement | 0001437749-25-037757 |
| 2025-11-26 | 16:05 ET | [8-K](/filings/0001437749-25-036447.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-036447 |
| 2025-11-13 | 17:20 ET | [8-K](/filings/0001437749-25-034903.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034903 |
| 2025-11-13 | 16:03 ET | [10-Q](/filings/0001437749-25-034811.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034811 |
| 2025-10-17 | 16:41 ET | [S-1](/filings/0001437749-25-031281.md) | Registration statement | 0001437749-25-031281 |
| 2025-10-14 | 16:29 ET | [DEF 14A](/filings/0001437749-25-030934.md) | Proxy statement, period 2025-11-26 | 0001437749-25-030934 |
| 2025-09-30 | 16:43 ET | [8-K](/filings/0001437749-25-030125.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-030125 |
| 2025-08-01 | 16:31 ET | [8-K](/filings/0001437749-25-024389.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-25-024389 |
| 2025-07-29 | 17:35 ET | [8-K](/filings/0001437749-25-023689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-023689 |
| 2025-07-28 | 16:11 ET | [10-Q](/filings/0001437749-25-023651.md) | Quarterly report, period 2025-06-30 | 0001437749-25-023651 |
| 2025-07-02 | 16:22 ET | [8-K](/filings/0001437749-25-021990.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-021990 |
| 2025-06-26 | 17:29 ET | [S-1/A](/filings/0001437749-25-021364.md) | Registration statement, amended | 0001437749-25-021364 |
| 2025-06-16 | 16:38 ET | [S-1](/filings/0001437749-25-020507.md) | Registration statement | 0001437749-25-020507 |
| 2025-06-05 | 16:40 ET | [8-K](/filings/0001437749-25-019563.md) | 5.07 Shareholder vote results | 0001437749-25-019563 |
| 2025-05-01 | 16:58 ET | [8-K](/filings/0001437749-25-014147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-014147 |
| 2025-05-01 | 16:01 ET | [10-Q](/filings/0001437749-25-014083.md) | Quarterly report, period 2025-03-31 | 0001437749-25-014083 |
| 2025-04-14 | 16:28 ET | [8-K](/filings/0001437749-25-011926.md) | 1.02 Termination of a material agreement | 0001437749-25-011926 |
| 2025-04-14 | 16:11 ET | [DEF 14A](/filings/0001437749-25-011916.md) | Proxy statement, period 2025-06-05 | 0001437749-25-011916 |
| 2025-03-28 | 16:14 ET | [8-K](/filings/0001437749-25-009859.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-009859 |
| 2025-03-27 | 16:05 ET | [10-K](/filings/0001437749-25-009614.md) | Annual report, period 2024-12-31 | 0001437749-25-009614 |
| 2025-03-25 | 16:14 ET | [8-K](/filings/0001437749-25-009141.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-009141 |
| 2025-01-22 | 16:01 ET | [8-K](/filings/0001437749-25-001556.md) | 5.07 Shareholder vote results | 0001437749-25-001556 |
| 2024-12-18 | 16:09 ET | [8-K](/filings/0001437749-24-037842.md) | 8.01 Other events | 0001437749-24-037842 |
| 2024-11-18 | 16:02 ET | [8-K](/filings/0001437749-24-035609.md) | 3.01 Delisting notice | 0001437749-24-035609 |
| 2024-11-13 | 16:13 ET | [8-K](/filings/0001437749-24-034910.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034910 |

Page 1 of 8. [Older](/companies/govx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 13:01 ET. No prices; not investment advice.